The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins | Science Translational Medicine
A longitudinal analysis after XBB.1.5 COVID-19 vaccination revealed durable neutralizing antibodies against ancestral and recent SARS-CoV-2 variants.
